Shares of Cynapsus Therapeutics Inc. jumped over 112% in extended trading on Wednesday, following news that the company will be acquired by privately-held Sunovion Pharmaceuticals Inc. for US$40.50 per share.
from RTT - Biotech http://ift.tt/2bEtLng
via IFTTT
No comments:
Post a Comment